DataM Blog

Sample DataM resources that are widely useful for your reference. We have curated special links for you to browse through

blog categories

Food and Beverage Healthcare Agriculture Chemicals and Materials Information & Communications Technology Electronics & Semiconductor Energy and Power Automotive and Aviation Consumer Goods Others

Top Companies Advancing Nanotechnology in Drug Delivery Systems

Nanotechnology in drug delivery is transforming modern healthcare by enabling targeted, controlled, and efficient delivery of therapeutic agents at the molecular level. Leading pharmaceutical and biotechnology companies are investing heavily in nanomedicine to improve treatment outcomes, reduce side effects, and enhance precision medicine approaches. This blog highlights key companies driving innovation in nanotechnology-based drug delivery systems across global healthcare and life sciences industries.

June 26, 2026

Can Healthcare Robotics Solve the Hospital Workforce Crisis? Market Trends, Technologies, and Future Opportunities

Healthcare systems worldwide face an unprecedented workforce shortage driven by aging populations, rising patient volumes, clinician burnout, and increasing operational costs. To address these challenges, hospitals are rapidly adopting healthcare robotics systems that automate repetitive tasks, improve surgical precision, enhance rehabilitation outcomes, and optimize hospital logistics. From robotic-assisted surgery and pharmacy automation to autonomous hospital delivery robots and AI-powered rehabilitation platforms, healthcare robotics is transforming the future of care delivery. As healthcare providers seek scalable solutions to workforce constraints, the global healthcare robotics systems market is emerging as one of the fastest-growing segments within healthcare technology. According to DataM Intelligence analysis, continued investments in hospital automation, minimally invasive surgery, and intelligent healthcare infrastructure are expected to accelerate market growth through 2035.

June 25, 2026

Which Neurological Rare Disease Treatment Brands Stand Out for Competitive Pricing?

The global rare neurological disease drugs market is undergoing rapid transformation driven by precision medicine, orphan drug incentives, and escalating treatment costs. As demand rises for therapies targeting conditions such as spinal muscular atrophy (SMA), multiple sclerosis-related rare syndromes, Huntington’s disease, and lysosomal storage disorders, pricing competitiveness has become a decisive factor for payers, healthcare providers, and investors. This article analyzes leading pharmaceutical brands, their pricing strategies, and how competitive positioning is reshaping access, adoption, and long-term market share in the rare neurological disease treatment landscape.

June 19, 2026

The GLP-1 Race: Obesity, Oral Therapies, Triple Agonists, and the $150 Billion Metabolic Health Opportunity

A strategic intelligence article analyzing how next-generation GLP-1 drugs, oral therapies, dual and triple agonists, and metabolic disease pipelines are reshaping the global obesity therapeutics market through 2035.

June 10, 2026

NASH/MASH Treatment: Symptoms, Causes, Diet, Medicines and What’s New

NASH, now commonly called MASH, is a serious form of fatty liver disease linked to obesity, diabetes and metabolic health. This guide explains symptoms, diagnosis, treatment options, diet, medicines and new FDA-approved therapies in simple language.

June 9, 2026

Why Medical Battery Safety Became the defining Industry Shift of 2026

Explore why medical battery safety became a defining industry shift in 2026. Learn how implantable devices, wearable technologies, AI-driven healthcare systems, and remote patient monitoring are driving demand for safer and more reliable medical battery solutions.

June 4, 2026